Press Release – Collaboration with Anagenesis on DMD

Posted by | No Tags | news | Comments Off on Press Release – Collaboration with Anagenesis on DMD

Together with Anagenesis Biotechnologies, Ksilink reachs first exit point in the field of Duchenne Muscular Disease. A major industrial Venture Fund invests into  Anagenesis with a € 3 M seed funding and subsequently up to € 15 M round A investment within the next 18 months. Click here to download the press release.


No Comments

Comments are closed.